相关实验视频
Updated: Jul 26, 2025

04:45
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
2.3K
内皮功能障碍在败血症患者中引发急性呼吸困扰综合征:叙述性综述
Rachael Cusack1,2, Lieuwe D Bos3, Pedro Povoa4,5,6
1Department of Intensive Care, St. James's Hospital, Dublin, Ireland.
Frontiers in medicine
|June 19, 2023
概括
急性呼吸窘迫综合征 (ARDS) 是一种严重的疾病,通常是由败血症引起的. 本综述探讨了ARDS机制,重点关注内皮损伤和个性化治疗策略,以获得更好的患者结果.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 病理生理学 病理生理学
背景情况:
- 急性呼吸困扰综合征 (ARDS) 是一种严重的疾病,其特征是急性呼吸衰竭和低氧化.
- 败血症是ARDS的主要原因,导致显著的死亡率和医疗保健资源利用率.
- 内皮损伤是ARDS病原和进展的关键因素.
研究的目的:
- 阐明ARDS的病原遗传机制和异质性.
- 检查内皮损伤在ARDS相关器官衰竭中的作用.
- 探索未来的治疗策略,针对ARDS中的内皮功能障碍.
主要方法:
- 这项研究是一个叙事性综述.
- 关于ARDS病变发生,内皮损伤和治疗策略的文献搜索.
- 对ARDS表型化生物化学信号的现有研究进行分析.
主要成果:
- 内皮损伤显著导致ARDS的发展和严重程度.
- ARDS表现出异质性,需要个性化治疗方法.
- 生物化学标志物显示出对针对性治疗的ARDS表型进行分类的潜力.
结论:
- 了解ARDS的发病因子,特别是内皮损伤,对于开发新的诊断和治疗点至关重要.
- 以患者表型为指导的个性化医疗为改善ARDS治疗疗效提供了一个有希望的途径.
- 为了管理ARDS,需要对内皮细胞保护策略进行进一步的研究.
相关概念视频
Acute Respiratory Failure-II
287
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
287
Acute Respiratory Failure-V
169
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169
Acute Respiratory Failure-I
253
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
253
Acute Respiratory Failure-IV
181
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
181
Acute Respiratory Failure-III
234
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
234
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K

